e. Risk of transmission

 

Paul Nicoletti

10:15

Break

10:45

f. Relationship among serology, culture test results, and likelihood of infectiousness

 

Tom Roffe

 

g. Genetic diversity and disease resistance in bison with active disease eradication

 

Joe Templeton

 

h. Molecular biology and Brucella abortus

 

Peter Gogan

12:15

Lunch break

1:30

i. Modelling

 

Mike Miller

 

k. Population changes and distribution

 

Mary Meagher

3:15

Break

3:45

m. Population dynamics, preliminary data

 

Peter Gogan

 

n. Issues in vaccination

 

Fred Enright; Phil Elzer

 

o. Safety and effectiveness of existing vaccines

 

Steve Olsen

5:00

Adjourn

25 June 1997

 

8:45

p. Elk as a reinfection pathway for bison

 

Terry Kreeger

 

q. Outcomes for vaccination program specific to bison given the presence of Brucella abortus in elk and other wildlife

 

Terry Kreeger



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement